Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02199665
Title Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Acronym SINE
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Chicago
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic (AZ) ACTIVE_NOT_RECRUITING Scottsdale Arizona 85259 United States Details
University of Chicago RECRUITING Chicago Illinois 60637 United States Details
University of Michigan Comprehensive Cancer Center ACTIVE_NOT_RECRUITING Ann Arbor Michigan 48109 United States Details
Wayne State University Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
Mount Sinai Medical Center RECRUITING New York New York 10029 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field